PMC3826807_01
Tumour outgrowth, 2 cm in diameter.
can-7-373fig1.jpg
PMC3826807_01_can-7-373fig1.jpg
figure1
A 2-cm vascularised tumour outgrowth, indurated and bleeding, was found on investigation (Figure 1); colposcopy revealed an area of type 1 changes, with a vascularised lesion approximately 2 cm in diameter, extending from the cervical canal to the posterior labium; this was biopsied.
A histological investigation of clear cell adenocarcinoma.
can-7-373fig2.jpg
PMC3826807_01_can-7-373fig2.jpg
figure2
A histopathological analysis of the specimen showed it to be a clear cell adenocarcinoma (Figure 2) with a Ki67 index of 60%, low-to-moderate nuclear immunoreactivity for p53 and cytokeratin 7, and negative hormone receptors.
MRI: 25-mm cervical lesion with no infiltration into the parametria.
can-7-373fig3.jpg
PMC3826807_01_can-7-373fig3.jpg
figure3
Magnetic resonance imaging (MRI) was also carried out and revealed a cervical lesion 25 mm in diameter with no infiltration into the parametria (Figure 3).
Identification of SLN in the area of the right external iliac vessels.
can-7-373fig4.jpg
PMC3826807_01_can-7-373fig4.jpg
figure4
Tc-99m (10 MBq in 0.2 mL of saline solution in each injection) and lymphoscintigraphy prior to surgery. Subsequently, in the operating theatre, 4 mL of undiluted methylene blue was injected into the same points (1 mL at each point), and one lymph node was identified in the external iliac vessels on either side. These were removed laparoscopically; intraoperative analysis found them to be negative (Figure 4).
The surgical specimen including the cervix and parametria following the RVT.
can-7-373fig5.jpg
PMC3826807_01_can-7-373fig5.jpg
figure5
Next, an RVT was carried out, with no complications (Figure 5).